Cargando…
ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial
BACKGROUND: TB and HIV form a deadly synergy in much of the developing world, especially Africa. Interventions to reduce the impact of these diseases at community level are urgently needed. This paper presents the design of a community randomised trial to evaluate the impact of two complex intervent...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585552/ https://www.ncbi.nlm.nih.gov/pubmed/18992133 http://dx.doi.org/10.1186/1745-6215-9-63 |
_version_ | 1782160843615502336 |
---|---|
author | Ayles, Helen M Sismanidis, Charalambos Beyers, Nulda Hayes, Richard J Godfrey-Faussett, Peter |
author_facet | Ayles, Helen M Sismanidis, Charalambos Beyers, Nulda Hayes, Richard J Godfrey-Faussett, Peter |
author_sort | Ayles, Helen M |
collection | PubMed |
description | BACKGROUND: TB and HIV form a deadly synergy in much of the developing world, especially Africa. Interventions to reduce the impact of these diseases at community level are urgently needed. This paper presents the design of a community randomised trial to evaluate the impact of two complex interventions on the prevalence of tuberculosis (TB) in high HIV prevalence settings in Zambia and South Africa. METHODS: The interaction between TB and HIV is reviewed and possible interventions that could reduce the prevalence of TB in HIV-endemic populations are discussed. Two of these interventions are described in detail and the design of a 2 × 2 factorial community randomised trial to test these interventions is presented. The limitations and challenges of the design are identified and discussed. CONCLUSION: There is an urgent need to reduce the prevalence of TB in communities highly affected by HIV. Potential interventions are complex and require innovative trial designs to provide the rigorous evidence needed to inform health policy makers and to ensure that resources are used optimally. TRIAL REGISTRATION: Number: ISRCTN36729271 |
format | Text |
id | pubmed-2585552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-25855522008-11-21 ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial Ayles, Helen M Sismanidis, Charalambos Beyers, Nulda Hayes, Richard J Godfrey-Faussett, Peter Trials Study Protocol BACKGROUND: TB and HIV form a deadly synergy in much of the developing world, especially Africa. Interventions to reduce the impact of these diseases at community level are urgently needed. This paper presents the design of a community randomised trial to evaluate the impact of two complex interventions on the prevalence of tuberculosis (TB) in high HIV prevalence settings in Zambia and South Africa. METHODS: The interaction between TB and HIV is reviewed and possible interventions that could reduce the prevalence of TB in HIV-endemic populations are discussed. Two of these interventions are described in detail and the design of a 2 × 2 factorial community randomised trial to test these interventions is presented. The limitations and challenges of the design are identified and discussed. CONCLUSION: There is an urgent need to reduce the prevalence of TB in communities highly affected by HIV. Potential interventions are complex and require innovative trial designs to provide the rigorous evidence needed to inform health policy makers and to ensure that resources are used optimally. TRIAL REGISTRATION: Number: ISRCTN36729271 BioMed Central 2008-11-07 /pmc/articles/PMC2585552/ /pubmed/18992133 http://dx.doi.org/10.1186/1745-6215-9-63 Text en Copyright © 2008 Ayles et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Study Protocol Ayles, Helen M Sismanidis, Charalambos Beyers, Nulda Hayes, Richard J Godfrey-Faussett, Peter ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial |
title | ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial |
title_full | ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial |
title_fullStr | ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial |
title_full_unstemmed | ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial |
title_short | ZAMSTAR, The Zambia South Africa TB and HIV Reduction study: Design of a 2 × 2 factorial community randomized trial |
title_sort | zamstar, the zambia south africa tb and hiv reduction study: design of a 2 × 2 factorial community randomized trial |
topic | Study Protocol |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2585552/ https://www.ncbi.nlm.nih.gov/pubmed/18992133 http://dx.doi.org/10.1186/1745-6215-9-63 |
work_keys_str_mv | AT ayleshelenm zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial AT sismanidischaralambos zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial AT beyersnulda zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial AT hayesrichardj zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial AT godfreyfaussettpeter zamstarthezambiasouthafricatbandhivreductionstudydesignofa22factorialcommunityrandomizedtrial |